Excellent
Mostly Aligned
Patient Risk:
Low
Summary
The evaluated claim is directly and explicitly supported by the provided Propecia FDA label text: indication is for men only, and the label states it is not indicated for use in women.
Category Scores
Accurate Statements
Propecia is indicated for men only, not women, for male pattern hair loss (androgenetic alopecia).
Indications and Usage: “PROPECIA® is indicated for the treatment of male pattern hair loss (androgenetic alopecia) in MEN ONLY.” and “PROPECIA is not indicated for use in women.”
Women are not indicated users (supported by contraindication/pregnancy messaging).
Contraindications: “Pregnancy. Finasteride use is contraindicated in women when they are or may potentially be pregnant.”
The label reinforces that Propecia is not indicated for use in women (supported by warnings/precautions and women’s study).
Warnings/Precautions (5.1): “PROPECIA is not indicated for use in women.”; Clinical Studies (14.2): women study shows effectiveness could not be demonstrated.
Unsupported Statements
Contradictions
Important Omissions
Safety Assessment
Potential Patient Risk:
Low
The statement evaluated concerns population indication (men only vs women). The label explicitly supports this restriction.
Regulatory Assessment
| On Label |
Yes |
| Off-label Discussion |
No |
| Promotes Unapproved Use |
No |
| Hallucination Risk |
Low |
Recommendation
Mostly Aligned
Primary Issue
Suggested Improvement